4.6 Article

Induction of SENP1 in Endothelial Cells Contributes to Hypoxia-driven VEGF Expression and Angiogenesis

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 285, 期 47, 页码 36682-36688

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M110.164236

关键词

-

资金

  1. State Key Laboratory of Oncogenes & Related Genes, National Natural Science Foundation of China [30772462]
  2. National Basic Research Program of China [2009CB918403, 2010CB912104]
  3. Shanghai Pujiang Program
  4. National Institutes of Health [CA 239520]

向作者/读者索取更多资源

SENP1 (SUMO-specific protease 1) has been shown to be essential for the stability and activity of hypoxia-inducible factor 1 (HIF-1 alpha) under hypoxia conditions. However, it is unknown how SENP1 activation and hypoxia signaling are coordinated in the cellular response to hypoxia. Here, we report the essential role of SENP1 in endothelial cells as a positive regulator of hypoxia-driven VEGF production and angiogenesis. SENP1 expression is increased in endothelial cells following exposure to hypoxia. Silencing of HIF-1 alpha blocks SENP1 expression in cell response to hypoxia. Mutation of the hypoxia response element (HRE) on the Senp1 promoter abolishes its transactivation in response to hypoxia. Moreover, silencing of SENP1 expression decreases VEGF production and abrogates the angiogenic functions of endothelial cell. We also find that the elongated endothelial cells in embryonic brain section and vascular endothelial cells in embryonic renal glomeruli in Senp1(-/-) mice are markedly reduced than those in wild-type. Thus, these results show that hypoxia implies a positive feedback loop mediated by SENP1. This feedback loop is important in VEGF production, which is essential for angiogenesis in endothelial cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

FBXO22 degrades nuclear PTEN to promote tumorigenesis

Meng-Kai Ge, Na Zhang, Li Xia, Cheng Zhang, Shuang-Shu Dong, Zhan-Ming Li, Yan Ji, Min-Hua Zheng, Jing Sun, Guo-Qiang Chen, Shao-Ming Shen

NATURE COMMUNICATIONS (2020)

Article Cell Biology

P53 suppresses SENP3 phosphorylation to mediate G2 checkpoint

Yang Wang, Jing Tian, Chao Huang, Jiao Ma, Gaolei Hu, Yalan Chen, Tianshi Wang, Rong Cai, Yong Zuo, Hongsheng Tan, Qiuju Fan, Baijun Dong, Wei Xue, Jing Yi, Guoqiang Chen, Jun Tu, Jinke Cheng

CELL DISCOVERY (2020)

Article Cell & Tissue Engineering

FAM122A Inhibits Erythroid Differentiation through GATAI

Jing Chen, Qiong Zhou, Man-Hua Liu, Yun-Sheng Yang, Yin-Qi Wang, Ying Huang, Guo-Qiang Chen

STEM CELL REPORTS (2020)

Letter Oncology

FAM122A is required for hematopoietic stem cell function

Man-Hua Liu, Xiao-Cui Zhang, Jing Chen, Yun-Sheng Yang, Yin-Qi Wang, Jun-Ke Zheng, Guo-Qiang Chen, Ying Huang

LEUKEMIA (2021)

Article Immunology

Lipid Receptor G2A-Mediated Signal Pathway Plays a Critical Role in Inflammatory Response by Promoting Classical Macrophage Activation

Qing Li, Chunlei Feng, Lingyun Li, Guiliang Xu, Haijuan Gu, Shiqiang Li, Dali Li, Mingyao Liu, Shuhua Han, Biao Zheng

Summary: This study demonstrates the important role of Lp-PLA(2) in controlling inflammatory macrophage polarization in autoimmune encephalomyelitis and multiple sclerosis. Lp-PLA(2) affects M1 function through lysophosphatidylcholine-mediated pathways and G2A receptor guidance, which could potentially lead to new therapeutic approaches for MS and other inflammatory disorders.

JOURNAL OF IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Epithelial cells-enriched lncRNA SNHG8 regulates chromatin condensation by binding to Histone H1s

Ping He, Cheng Zhang, Yan Ji, Meng-Kai Ge, Yun Yu, Na Zhang, Shuo Yang, Jian-Xiu Yu, Shao-Ming Shen, Guo-Qiang Chen

Summary: SNHG8, a chromatin-localized lncRNA, interacted and phase separated with histone H1 variants. It showed stronger binding ability to H1 proteins than linker DNA, leading to increased chromatin condensation and epithelial cell differentiation.

CELL DEATH AND DIFFERENTIATION (2022)

Article Chemistry, Medicinal

Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8H)-one Derivatives as Novel Potent Adenosine A2A Receptor Antagonists for Cancer Immunotherapy

Fazhi Yu, Chenyu Zhu, Shuyin Ze, Haojie Wang, Xinyu Yang, Mingyao Liu, Qiong Xie, Weiqiang Lu, Yonghui Wang

Summary: Compound 57 demonstrates potential as a novel A(2A) receptor antagonist in cancer immunotherapy, enhancing T cell activation and inhibiting adenosine levels in the tumor microenvironment.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

MUC1 triggers lineage plasticity of Her2 positive mammary tumors

Zhi Pang, Xinran Dong, Huayun Deng, Chengzhi Wang, Xiaodong Liao, Chunhua Liao, Yahui Liao, Weidong Tian, Jinke Cheng, Guoqiang Chen, Haiying Yi, Lei Huang

Summary: Aberrant overexpression of MUC1 and HER2 is associated with breast cancer, and their concomitant expression leads to worse clinical outcome. In a mouse model, coexpression of Her2 and MUC1-CD promotes mammary tumor development and induces changes in tumor lineage plasticity and downregulation of tricarboxylic acid cycle genes. Furthermore, MUC1 enhances the Her2 signaling pathway by inducing Her2/Egfr dimerization.

ONCOGENE (2022)

Article Multidisciplinary Sciences

The phosphatase PTEN links platelets with immune regulatory functions of mouse T follicular helper cells

Xue Chen, Yanyan Xu, Qidi Chen, Heng Zhang, Yu Zeng, Yan Geng, Lei Shen, Fubin Li, Lei Chen, Guo-Qiang Chen, Chuanxin Huang, Junling Liu

Summary: PTEN-deficient platelets promote autoimmunity in mouse models through excessive activation of T-FH cells and systemic autoimmune pathology.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia

Chunyang Yi, Jiacheng He, Dan Huang, Yumiao Zhao, Chan Zhang, Xiyun Ye, Ying Huang, Ruth Nussinov, Junke Zheng, Mingyao Liu, Weiqiang Lu

Summary: Activation of the orphan GPCR GPR132 induces cell differentiation in acute myeloid leukemia (AML) and the natural product 8-gingerol is found to be a potential GPR132 agonist, promoting differentiation and reducing colony formation in AML cell lines.

CELL DEATH & DISEASE (2022)

Article Multidisciplinary Sciences

Cryo-EM structure of the human adenosine A2B receptor-Gs signaling complex

Ying Chen, Jinyi Zhang, Yuan Weng, Yueming Xu, Weiqiang Lu, Wei Liu, Mingyao Liu, Tian Hua, Gaojie Song

Summary: This study presents the structures of the human adenosine A2B receptor (A2BR) bound to its agonists NECA and BAY60-6583, elucidating the orthosteric binding pockets and their subtle differences. Selectivity is mainly determined by regions extended from the orthosteric pocket, and the key determinants for BAY60-6583's selectivity against A2BR are identified. This study provides a better understanding of ligand selectivity in the adenosine receptor family and offers a structural template for the development of A2BR ligands for related diseases.

SCIENCE ADVANCES (2022)

Article Chemistry, Medicinal

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance

Peng He, Juanjuan Feng, Xinting Xia, Yue Sun, Jia He, Tian Guan, Yangrui Peng, Xueli Zhang, Mingyao Liu, Xiufeng Pang, Yihua Chen

Summary: HP661 is a highly effective OXPHOS inhibitor that can inhibit mitochondrial oxygen consumption in high OXPHOS lung cancer cells. It also shows significant sensitivity in MEK inhibitor-resistant lung cancer cells and has therapeutic efficacy against high OXPHOS lung cancer.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A2A Receptor Antagonists for Cancer Immunotherapy

Chenyu Zhu, Shuyin Ze, Ronghui Zhou, Xinyu Yang, Haojie Wang, Xiaolei Chai, Meimiao Fang, Mingyao Liu, Yonghui Wang, Weiqiang Lu, Qiong Xie

Summary: Recent studies and clinical evidence have shown that adenosine A2A receptor (A2AR) antagonists have great potential as novel approaches for cancer immunotherapy. Through the screening of a compound library, a pyridinone hit compound with weak A2AR antagonistic activity was identified, and further studies led to the discovery of a series of pyridinone derivatives with strong potency. Compound 38 demonstrated potent A2AR antagonistic activity, good metabolic stability, and excellent oral bioavailability, and also effectively enhanced the activation and killing ability of T cells. In addition, it exhibited excellent in vivo antitumor activity, making it a promising candidate for cancer immunotherapy.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A2A Receptor Antagonists for Cancer Immunotherapy

Chenyu Zhu, Shuyin Ze, Ronghui Zhou, Xinyu Yang, Haojie Wang, Xiaolei Chai, Meimiao Fang, Mingyao Liu, Yonghui Wang, Weiqiang Lu, Qiong Xie

Summary: Recent studies and clinical evidence have shown that adenosine A2A receptor (A2AR) antagonists have great potential in cancer immunotherapy. Through screening, compound 38, a pyridinone derivative, was identified as a potent A2AR antagonist with good stability and high bioavailability. Furthermore, compound 38 effectively enhanced the activation of T cells in vitro and demonstrated excellent antitumor activity in vivo, making it a promising candidate for cancer immunotherapy.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Oncology

FAM122A maintains DNA stability possibly through the regulation of topoisomerase IIα expression

Yin-Qi Wang, Yun-Sheng Yang, Jing Chen, Man-Hua Liu, Guo-Qiang Chen, Ying Huang

EXPERIMENTAL CELL RESEARCH (2020)

暂无数据